Researchers introduced Detectrons, engineered biosensors that convert specific RNA sequences inside living cells into stable DNA barcodes readable by high-throughput sequencing. The system uses toehold-switch biosensors coupled to retron reverse transcription to create lasting molecular records of RNA activity. Because RNA is typically transient, the method’s core value is transforming fleeting RNA signals into durable genetic outputs without requiring cell fixation at the moment of RNA expression. This can broaden experimental design options in developmental biology, cancer research, and dynamic pathway mapping. The technical significance is practical: if barcoding is efficient and sequence-specific in heterogeneous cell populations, it can improve throughput and reduce the need for repeated invasive sampling. For biotech teams, the relevance is clear—barcoding platforms can accelerate discovery work in mechanisms of action, lineage tracking, and RNA regulatory dynamics.